A small piece of the multibillion-dollar restructuring at Pfizer has a light at the end of the tunnel, and it’s in Boulder, CO.
Just a …
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
After private equity acquisition, medical centers had an increase in hospital-acquired adverse events, despite a shift to a lower-risk case mix, a study of Medicare
Listen to the article 5 min This audio is auto-generated. Please let us know if you have feedback. Dive Brief: The Food and Drug Administration
Patients with Niemann-Pick disease type C who received N-acetyl-L-leucine (NALL), an agent that potentially ameliorates lysosomal and metabolic dysfunction, showed reduced neurologic signs and symptoms